Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1984;107(2):99-105.
doi: 10.1007/BF00399380.

Chemotherapy in advanced ovarian cancer

C J Rodenburg, F J Cleton
Review

Chemotherapy in advanced ovarian cancer

C J Rodenburg et al. J Cancer Res Clin Oncol. 1984.

Abstract

The chemotherapy of advanced ovarian cancer is reviewed. Treatment with single agents results in low remission rates and few complete remissions. The results have been improved with modern combination chemotherapy, which includes cisplatin, although a longer follow up is needed for definite conclusions to be made concerning survival. Toxicity and drug resistance remain important problems. The future prospects of treatment with emphasis on intraperitoneal chemotherapy are discussed.

PubMed Disclaimer

References

    1. Barker, GH, Wiltshaw E (1981) Randomized trial comparing low dose cisplatin and chlorambucil with advanced ovarian cancer. Lancet i:747–750 - DOI - PubMed
    1. Barlow JJ, Blumenson LE (1979) Letter to the editor. New Eng J Med 22:676
    1. Bruckner HW, Cohen CJ, Goldberg JD, Kabakow B, Wallach RC, Deppe G, Greenspan EM, Gusberg SB, Holland JF (1981) Improved chemotherapy for ovarian cancer with cis-diaminedichloroplatinum and adriamycin. Cancer 47:2288–2294 - PubMed
    1. Bush RS (1979) Letter to the editor. New Eng J Med 22:676
    1. Carmo Pereira J, Costa FO, Henriques E, Ricardo JA (1981) Advanced ovarian carcinoma: A prospective and randomized clinical trial of cyclophosphamide versus combination cytotoxic chemotherapy (HexaCAF). Cancer 48:1947–1951 - PubMed

LinkOut - more resources